19:50 EDT Atara Biotherapeutics trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRA:
- Atara Biotherapeutics announces 1-for-25 reverse stock split
- Atara Biotherapeutics presents preclinical ATA3219 data at ISCT 2024
- Adiumentum Capital reports 6.7% stake in Atara Biotherapeutics
- Atara Biotherapeutics submits BLA to FDA for tabelecleucel
- Atara Biotherapeutics reports Q1 EPS (23c), consensus (26c)